Oakmark U.S. Concentrated ETF (OAKL) closed at $26.88 on November 3, 2026, down 1.0% from the previous close, on volume of 2,978 shares (30-day average 68,943).
Data as of November 3, 2026.
No headlines found.
No press releases found.
No news found.
Oakmark U.S. Concentrated ETF seeks long-term capital appreciation. Under normal circumstances, the Fund will invest at least 80% of its net assets in securities of U.S. companies. The Fund invests in a concentrated portfolio comprised of equity securities of larger U.S. companies. The Fund uses a value investment philosophy in selecting equity securities. This value investment philosophy is based upon the belief that, over time, a company's stock price converges with the Adviser's estimate of the company's intrinsic value. The Adviser uses this value investment philosophy to identify companies that have discounted stock prices compared to what the Adviser believes are the companies' intrinsic values. In making its investment decisions, the Adviser uses a "bottom-up" approach focused on individual companies, rather than focusing on specific economic factors or specific industries.
Oakmark U.S. Concentrated ETF trades on the ARCA stock market under the symbol OAKL.
As of November 3, 2026, OAKL stock price declined to $26.88 with 2,978 million shares trading.
OAKL has a market cap of $334.87 million. This is considered a Small Cap stock.
OAKL support price is $26.85 and resistance is $27.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OAKL shares will trade within this expected range on the day.
